Summary: A multinational clinical trial demonstrated that a novel antibody, NG101, successfully preserves existing nerve tissue and accelerates the regression of spinal cord lesions following acute ...

A neuro-oncologist at the Mayo Clinic reveals the telltale signs of a “classic brain tumor headache” and other brain tumor ...

Who they affect: Meningiomas are more common in older adults, especially women, with studies showing a 2.7% prevalence among 70-year-old women. When to act: Small, slow-growing tumors may only require ...

A brain tumor diagnosis can feel overwhelming. But knowing when surgery is necessary — and how to have the right convers ...

Depo-Provera ® has been linked to an increased risk of brain and spinal tumors known as meningiomas. If you were diagnosed with a meningioma after receiving Depo shots, you may be eligible to file a ...

A new spinal tumor drug has received FDA breakthrough therapy designation Early studies show a promising response rate of around 67% Further research is needed before the drug becomes widely available ...

The term “brain tumor” carries a particularly scary connotation. And if you’re a fan of TV medical dramas, you may think they’re quite common. However, less than 1% of Americans are living with a ...

CCSS follow-up of 24,886 five-year survivors (1970–1999 diagnoses) identified 471 individuals with 710 meningiomas, including frequent multiplicity (29% ≥2; 16% meningiomatosis).

Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the brain from cancer elsewhere). They can also ...

In December 2025, the U.S. Food and Drug Administration (FDA) approved the addition of meningioma brain tumor risks to the warning labels for Depo-Provera ®, a popular birth control injection ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...